Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy

Citation
Ah. Shevitz et al., Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy, AIDS, 13(11), 1999, pp. 1351-1357
Citations number
61
Categorie Soggetti
Immunology
Journal title
AIDS
ISSN journal
02699370 → ACNP
Volume
13
Issue
11
Year of publication
1999
Pages
1351 - 1357
Database
ISI
SICI code
0269-9370(19990730)13:11<1351:EREEAH>2.0.ZU;2-B
Abstract
Objectives: To ascertain the relationships between resting energy expenditu re (REE), HIV RNA in plasma, and highly active antiretroviral therapy (HAAR T). Design: Cross-sectional analysis using data of a large cohort study of nutr ition in relation to HIV disease. Methods: HIV RNA in plasma, REE, fat-free mass (FFM), and medication regime ns were assessed at 530 visits among 372 participants in a cohort study of HIV-seropositive men and women. Results: HIV RNA in plasma was directly correlated with REE. After adjustme nt for FFM, age, CD4 cell count and HAART use, there was an increase in REE of 90 kJ/day per log(10) copies/ml increase in HIV RNA [95% confidence int erval (CI) 16-164; P = 0.02). HAART use had an independent effect on REE. I n patients reporting HAART use, adjusted REE was 339 kJ/day higher than in those not reporting HAART use (95% CI 177-501; P = 0.0001). Conclusions: Viral load and HAART appear to exert independent effects on RE E. Although HAART may decrease metabolic rate by lowering viral burden, it appears to increase metabolic demands through some mechanism(s) independent of its effect on viral burden. This may result in elevated REE despite con trol of viral replication. (C) 1999 Lippincott Williams & Wilkins.